Clinical Trials Directory

Trials / Completed

CompletedNCT03654781

Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication

Periodontal Tedavinin Helikobakter Pilori Eradikasyon ve Rekürrensine Katkısının İncelenmesi

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Ondokuz Mayıs University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The efficacy of conventional systemic antibiotic therapy for eradication of gastric H. pylori has been seriously challenged by antibiotic resistance. Identification of alternative therapeutic strategies might help to overcome the limitation. The investigators' aim was to examine the effect of adjunct periodontal therapy, on gastric H. pylori eradication rate.

Conditions

Interventions

TypeNameDescription
DRUGTriple therapytriple therapy:a 10-day course of a Lansoprazole (proton pump inhibitor )combined with amoxicillin (2 × 1 g daily) and clarithromycin (2 × 500 mg daily).(trio)
PROCEDUREprofessional periodontal treatmentperiodontal treatment consisting of mechanical periodontal treatment (scaling and root planing) Oral hygiene insruction Periodontal treatment started concurrently with triple therapy

Timeline

Start date
2008-04-21
Primary completion
2011-07-07
Completion
2012-02-17
First posted
2018-08-31
Last updated
2018-08-31

Source: ClinicalTrials.gov record NCT03654781. Inclusion in this directory is not an endorsement.

Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication (NCT03654781) · Clinical Trials Directory